HPA axis function study in children with Allergic Rhinitis was presented at the annual meeting of the American College of Allergy Asthma and Immunology
On November 5, 2011,in Annals of Allergy, Asthma & Immunology, Nov. 2011, 107:5suppl.1,P364
Cypress, CA, November 5, 2011
West Coast Clinical Trials, LLC (WCCT) is pleased to announce the presentation of results of a Hypothalamic-Pituitary- Adrenal Axis function study in children ages 2 – 11 years of age with Allergic Rhinitis. One hundred thirty-two (132) children completed the trial. The children were treated with either NASACORT® AQ nasal spray or placebo for 6 weeks. No significant treatment effect compared to placebo was observed. WCCT was the highest enrolling site of the 3 centers chosen to carry out this important trial.
The ACAAI is a professional association of 5,000 allergists/immunologists. Established in 1942, the ACAAI is dedicated to improving the quality of patient care in allergy and immunology through research, advocacy and professional public education.
Contact: email@example.com for more information
WCCT is a privately owned early phase development contract research organization, conveniently located near 3 major airports in Southern California. WCCT was founded by Dr. Kenneth Kim who is board certified in Internal Medicine and Allergy and Immunology. Conducting trials since 1998, WCCT has been audited by the FDA and numerous pharmaceutical and biotechnology companies. WCCT’s location and access to an ethnically diverse population allows for a wide variety of study designs including ethnic bridging. With 150 beds in two locations and over 60,000 square feet, a well-trained and experienced staff, and advanced technological procedures, WCCT brings the highest quality to the pharmaceutical and biotechnology industries. (www.wcct.com)
West Coast Clinical Trials, LLC
Business Development 1-714.252.0783